MONDAY, April 21, 2025 — The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to refrain from using the imitation drugs.
Several…
You may also like
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Some OB/GYNS Stay in States With Abortion Bans...
Teen Cannabis Use Rises in Canada After Edibles Are...
Federal Prosecutor Questions Medical Journals Over...
Psilocybin Use Dramatically Increasing In U.S.
Muscle Quality Could Be Key To Successful Hip...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.